U.S. Personal Products Stock News

Alcoa and the Australian Federal Government have agreed to modernize environmental approvals for the company’s Western Australia mining operations. The package includes strategic environmental assessments through 2045, updated oversight of mining activities, and enforceable undertakings after unauthorized land clearing. Alcoa has committed significant funding to long term forest rehabilitation as part of the agreement. For investors watching NYSE:AA, this agreement sits alongside a share...

Ondas (NasdaqCM:ONDS) has secured multi year demining contracts along the Israel Syria border that are described as historic in scale for the region. The company is rolling out counter drone solutions with German State Police and entering the handheld C UAS market. These developments arrive as JCapital Research publishes a critical report questioning Ondas' business model and acquisition strategy. For investors tracking Ondas at a share price of $11.07, the stock has seen very large 1 year...

ICL Group (NYSE:ICL) has posted another steady quarter, with Q3 FY 2025 revenue of US$1.9 billion and basic EPS of US$0.09, supported by net income of US$115 million. Over the past few quarters, the company has seen revenue move from US$1.6 billion in Q4 FY 2024 to US$1.8 billion in Q2 FY 2025 and US$1.9 billion in Q3 FY 2025. Quarterly EPS has ranged between US$0.05 and US$0.09, setting up a results season in which investors are likely to focus closely on how resilient margins look from...

Prenetics Global (NasdaqGM:PRE) has just posted its FY 2025 third quarter numbers, with revenue of US$23.6 million and a basic EPS loss of US$0.40, keeping the company in loss-making territory. The company’s quarterly revenue has moved from US$10.5 million in Q4 2024 to US$17.3 million in Q1 2025, US$15.0 million in Q2 2025 and now US$23.6 million in Q3 2025. Over the same period, EPS losses have shifted from US$1.28 to US$0.80, US$0.64 and US$0.40. Investors are likely to weigh these results...

Huntsman (HUN) closed FY 2025 with fourth quarter revenue of US$1,355 million and a basic EPS loss of US$0.51, as the business continued to operate in the red on a trailing 12 month basis with EPS at a loss of US$1.59. Over the past six reported quarters, revenue has ranged between US$1,355 million and US$1,540 million, while basic EPS has stayed negative in every period. This highlights how top line stability has not yet translated into earnings stability. With analysts focused on a...

Wall Street brokerages have started coverage of EquipmentShare.com after its recent IPO, focusing on the company’s technology driven rental model. Analysts are highlighting EquipmentShare’s plans to expand its rental footprint and its capital light approach to fleet growth. The new coverage is drawing attention to the company’s goal of doubling rental locations and its position in the equipment rental industry. EquipmentShare.com, listed on NasdaqGS:EQPT, is coming onto more investors’...

If you are wondering whether Revvity at around US$97.74 is offering good value or just fair value, you are in the right place to unpack what the market might be pricing in. The stock has seen a 3.3% decline over the last 7 days, 13.1% over the last 30 days, and sits around a 0.4% year to date decline and a 14.8% decline over the past year. These moves can change how investors think about its growth potential and risk. Recent coverage of Revvity has focused on its role in the pharmaceuticals...

IQVIA Holdings (IQV) just closed out FY 2025 with Q4 revenue of US$4.4b and basic EPS of US$3.02, capping a year in which trailing 12 month revenue came in at US$16.3b and EPS reached US$7.91. Over the past few quarters, the company has seen revenue move from US$3.8b in Q1 2025 to US$4.1b in Q3 2025 and US$4.4b in Q4 2025. Quarterly EPS went from US$1.42 to US$1.94 to US$3.02, setting the stage for investors to weigh that earnings trajectory against an 8.3% net margin that sits below last...

Axcelis Technologies (ACLS) just wrapped up FY 2025 with Q4 revenue of US$238.3 million and basic EPS of US$1.11, alongside trailing twelve month revenue of US$839.0 million and EPS of US$3.81 that frame the latest quarter in a fuller earnings picture. Over recent periods, the company has seen quarterly revenue range from US$192.6 million to US$238.3 million and quarterly EPS move between US$0.83 and US$1.11. During the same time, trailing twelve month revenue moved from US$958.1 million to...

Tandem Diabetes Care (TNDM) shares finished the latest session at US$18.94, drawing attention after a period of mixed returns, including negative moves over the past month, past 3 months, year, and longer horizons. See our latest analysis for Tandem Diabetes Care. That 0.5% 1 day share price gain to US$18.94 sits against a softer backdrop, with a 30 day share price return of 6.1% and a 1 year total shareholder return decline of 40.3%, which suggests recent momentum is still fading as...

If you are wondering whether HP's current share price reflects its underlying value, this article will walk you through what the numbers are really saying. HP shares, which last closed at US$18.35, have seen returns of 7.1% decline over 7 days, 9.9% decline over 30 days, and 17.0% decline year to date, contributing to a 44.7% decline over 1 year and 29.4% decline over 3 years, with a 22.2% decline over 5 years. Recent news coverage has focused on HP's position in the broader tech sector and...

Why Emerson Electric’s new credit facility matters for shareholders Emerson Electric (EMR) has arranged a new US$2b 364 day credit facility that currently sits undrawn. This provides the company with added liquidity support while it continues to integrate past deals and address growth opportunities. See our latest analysis for Emerson Electric. Emerson’s new US$2b undrawn facility comes as the share price sits at US$151.14, with a 22.16% 90 day share price return and a 94.44% three year total...

United Community Banks (UCB) has wrapped up FY 2025 with fourth quarter revenue of US$264.7 million and basic EPS of US$0.71, supported by trailing twelve month revenue of US$1.0 billion and EPS of US$2.62. The bank has seen revenue move from US$901.2 million and EPS of US$2.04 over the prior trailing period to US$1.0 billion and EPS of US$2.62 most recently, alongside a net profit margin of 31.4% versus 27.1% a year earlier. This puts the focus firmly on how efficiently it is turning its top...

Blue Owl Capital (OWL) shares were in focus after the company posted fourth quarter and full year 2025 results, and affirmed its regular dividend, a combination that can reset expectations around income and growth potential. See our latest analysis for Blue Owl Capital. Despite the earnings and dividend news lifting the 1 day share price return to 1.90%, Blue Owl Capital’s 30 day share price return of 22.72% and 1 year total shareholder return of 46.74% point to fading momentum after earlier...

Elevance Health (ELV) is back in focus after another earnings beat, a higher outlook, and ongoing multibillion dollar share buybacks. This combination puts management decisions and capital return front and center for investors. See our latest analysis for Elevance Health. At a share price of US$346.24, Elevance Health has seen short term share price momentum pick up with a 7 day share price return of 3.0%. However, the 1 year total shareholder return of a 9.6% decline and 3 year total...

Waters Corporation (NYSE:WAT) introduced new high-sensitivity liquid chromatography columns featuring MaxPeak Premier Technology. The company completed a realignment of its operations into four focused divisions aimed at adjacent high-growth markets. Waters, a long-established player in analytical instruments and laboratory solutions, is using this product launch and business realignment to sharpen its role in analytical sciences and diagnostics. The new columns with MaxPeak Premier...

Assessing Eli Lilly after recent performance Eli Lilly (LLY) has drawn attention after a recent share price pullback, with the stock down about 2% over the past month and 2% over the past 3 months, prompting fresh questions on valuation. See our latest analysis for Eli Lilly. The recent pullback sits within a mixed picture, with a 1-day share price return of a 1.5% decline and a year-to-date share price return of a 5.5% decline. Meanwhile, the 1-year total shareholder return is 18.6% and the...

Ad-tech company EVA Live (Nasdaq:GOAI) has launched its first client-facing web application for NeuroServer.

Quad/Graphics (QUAD) closed out FY 2025 with fourth quarter revenue of $630.6 million and basic EPS of $0.23, alongside net income of $11.1 million. Over the past few quarters, the company has seen revenue move from $708.4 million and EPS of $0.10 in Q4 2024 through $629.4 million and $0.12 in Q1 2025, $571.9 million and roughly breakeven EPS in Q2 2025, then $588 million and $0.21 in Q3 2025. This frames a year where profitability settled in at a trailing twelve month EPS of $0.57 on $2.4...

HF Sinclair (DINO) has just posted its FY 2025 third quarter numbers, with revenue of US$7.3b and basic EPS of US$2.16, set against trailing 12 month earnings growth of 18.7%. The company has seen revenue move from US$7.2b in Q3 2024 to US$7.3b in Q3 2025, while quarterly EPS shifted from a loss of US$0.40 to EPS of US$2.16. The trailing net profit margin sits at 1.5% versus 1.1% last year, giving investors a clearer view of how the earnings profile is shaping up. Taken together, these...

Enpro (NPO) has put up another solid set of numbers for FY 2025 so far, with Q3 revenue at US$286.6 million and basic EPS of US$1.02. Trailing twelve month EPS sits at US$4.11 on US$1.1 billion of revenue. The company has seen revenue move from US$1.04 billion with EPS of US$2.58 over the twelve months to Q3 2024 to US$1.1 billion with EPS of US$4.11 over the latest twelve month window. This has come alongside earnings growth of 59.7% and an uptick in net profit margin from 5.2% to 7.8%,...

Beta Bionics (BBNX) just closed out FY 2025 with Q4 revenue of US$32.1 million and a net loss of US$13.5 million, which translated to EPS of US$0.30 loss, while trailing 12 month revenue reached US$100.3 million alongside a net loss of US$73.2 million and EPS of US$1.81 loss. Over recent quarters the company has seen revenue move from US$17.6 million and EPS of US$0.93 loss in Q1 2025 to US$27.3 million and EPS of US$0.33 loss in Q3 2025, before landing at the latest Q4 run rate. For...

Liberty Global (LBTY.A) has reported another tough set of numbers for FY 2025, with Q3 revenue of US$1,207.1 million and a basic EPS loss of US$0.27, alongside trailing 12 month revenue of US$4.8 billion and a basic EPS loss of US$5.47. Over recent periods, the company has seen revenue move from US$1,069.5 million in Q3 2024 to US$1,207.1 million in Q3 2025, while EPS has shifted from a loss of US$4.0 in Q3 2024 to a loss of US$0.27 in Q3 2025. Overall, the latest figures keep the spotlight...

Earlier this month, Jefferies began covering Levi Strauss & Co., highlighting its shift to a direct-to-consumer-first, head-to-toe denim lifestyle brand and the company’s focus on premium and lifestyle initiatives. Jefferies’ upbeat commentary, echoed by CEO Michelle Gass’s claim that Levi’s has reached an inflection point with faster growth and improved profitability, shines a light on how the brand’s repositioning could reshape expectations for its next phase. We’ll now examine how...